Mahkam Zanganeh - Co-Chief Executive Officer, Director at Summit Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Co-Chief Executive Officer, Director
Stock Symbol
SMMT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mahkam Zanganeh - trading volume in the past year for Summit Therapeutics Inc.

Holdings reported by Mahkam Zanganeh for Summit Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25M $567M $22.70 Sep 11, 2024 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee
Common Stock 9.88M $224M $22.70 Sep 11, 2024 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee.
Stock Option (right to buy) 12M $15.8M $1.32 Oct 13, 2023 Direct Common Stock
Common Stock 521K $11.8M $22.70 Sep 11, 2024 Direct
Common Stock 50K $1.14M $22.70 Sep 11, 2024 Immediate family member
Performance Stock Option (right to buy) 2.4M Aug 23, 2024 Direct Common Stock
Warrant (right to buy) 0 Dec 11, 2023 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee Common Stock
Warrant (right to buy) 0 Dec 11, 2023 Direct Common Stock

Transactions reported by Mahkam Zanganeh for Summit Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.